The specific aim of the Michigan Diabetes Research & Training Center Pilot/Feasibility Study (P/FS) Grant Program is to stimulate new research initiatives in the areas of diabetes and related endocrinology and metabolism disorders at the University of Michigan. These research initiatives may be in areas of basic or clinical biomedical science, behavioral science or in areas related the development of methodology for training patients and health care professionals. This program offers opportunities for new investigators to become involved in diabetes and endocrinology research, it encourages established investigators in other areas to focus their expertise on problems related to diabetes and endocrinology, and it enables established investigators in the field to explore new, high-risk directions that could become fruitful research areas. Each year, the Center solicits applications for P/FS grants from full-time faculty University-wide. These applications are peer-reviewed by both extramural and intramural experts in the area of the application. Only those having high scientific merit, as judged by this review process, receive P/F awards. The ultimate goal of the grant program is to enable awardees to generate a sufficient body of preliminary information for a successful application for major research funding from the NIH or other national granting agencies. During the 14 year history of the Michigan program more than half of the P/FS projects awarded have developed into fruitful extramurally-funded research programs. A major virtue of the P/FS grant program is that it attracts investigators from the various Schools and Institutes throughout the University of Michigan and in so doing has been a major force in forging the Center into an interdisciplinary unit.

Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kumar, Navasuja; Pop-Busui, Rodica; Musch, David C et al. (2018) Central Corneal Thickness Increase Due to Stromal Thickening With Diabetic Peripheral Neuropathy Severity. Cornea 37:1138-1142
Wilson, Matthew J; Sen, Ananda; Bridges, Dave et al. (2018) Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ?-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 139:14-19
Sucularli, Ceren; Thomas, Peedikayil; Kocak, Hande et al. (2018) High-throughput gene expression analysis identifies p53-dependent and -independent pathways contributing to the adrenocortical dysplasia (acd) phenotype. Gene 679:219-231
Kady, Nermin M; Liu, Xuwen; Lydic, Todd A et al. (2018) ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability. Diabetes 67:769-781
Malik, Ahmed M; Miguez, Roberto A; Li, Xingli et al. (2018) Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife 7:
Lee, Pearl G; Ha, Jinkyung; Blaum, Caroline S et al. (2018) Patterns of physical activity in sedentary older individuals with type 2 diabetes. Clin Diabetes Endocrinol 4:7
Ramos, Carla J; Lin, Chengmao; Liu, Xuwen et al. (2018) The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability. J Biol Chem 293:717-730
Djuric, Zora; Bassis, Christine M; Plegue, Melissa A et al. (2018) Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations. J Acad Nutr Diet 118:606-616.e3
Vollbrecht, Peter J; Nesbitt, Kathryn M; Mabrouk, Omar S et al. (2018) Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone rats. Behav Brain Res 346:137-143
Jiang, Lin; Su, Haoran; Keogh, Julia M et al. (2018) Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression. FASEB J 32:1830-1840

Showing the most recent 10 out of 1081 publications